Swiss contract drug manufacturer Lonza has set new mid-term targets and reaffirmed its 2026 outlook, announcing a focus on drug manufacturing and major growth strategies during its capital markets day ...
GSK plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring initiative aimed at saving £1.9 billion.
Cipla has issued a voluntary recall of its Fosfomycin Tromethamine Granules for Oral Solution in the US after it failed to ...
A new drug, ANB033, shows promise in treating gluten-caused intestinal damage in celiac patients, providing significant ...
Vir Biotechnology has entered a groundbreaking collaboration with Gilead Sciences, valued at up to $1.88 billion, to develop ...
Expanding testing infrastructure critical to support MedTech growth: Poly Med’s Indranil Mukherjee
India’s MedTech manufacturers have made steady progress in recent years, but further development of testing infrastructure ...
Sanofi has avoided a potential fine from the EU by promising to cease disparaging the rival flu vaccine Fluad, made by CSL ...
Biocon has reached an agreement with Roche to launch its biosimilar of the cancer drug Perjeta, with rollouts planned from ...
Biodeal Pharmaceuticals is looking to expand its injectable business, leveraging its newly acquired Paonta Sahib plant from ...
Johnson & Johnson's Q3 earnings exceed expectations, driven by pharmaceutical sales but impacted by geopolitical issues and a sluggish medical devices market. Discover the company's strategies and ...
BioNTech's experimental mRNA cancer immunotherapy BNT113 did not meet its primary goal in a head and neck cancer trial, ...
ETPharma.com brings latest obesity drug news, views and updates from all top sources for the Indian Pharma industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results